Amicus Therapeutics

Amicus Therapeutics and ARYA Sciences Acquisition Corp IV Announce Formation of “Caritas Therapeutics”

PHILADELPHIA, PA — Amicus Therapeutics, Inc. (Nasdaq: FOLD) announced its intent to launch a next-generation genetic medicine company, Caritas Therapeutics, Inc., through a definitive business combination agreement pursuant to which …

Amicus Therapeutics and ARYA Sciences Acquisition Corp IV Announce Formation of “Caritas Therapeutics” Read More